Immuron Ltd logo

Immuron Ltd

ASX:IMC (Australia)  
A$ 0.11 (-4.55%) Apr 12
At Loss
P/B:
1.36
Market Cap:
A$ 23.92M ($ 15.52M)
Enterprise V:
A$ 5.11M ($ 3.32M)
Volume:
432.87K
Avg Vol (2M):
2.09M
Also Trade In:
Volume:
432.87K
At Loss

Business Description

Description
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Name Current Vs Industry Vs History
Cash-To-Debt 86.87
Equity-to-Asset 0.88
Debt-to-Equity 0.01
Debt-to-EBITDA -0.05
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.97
Distress
Grey
Safe
Beneish M-Score -2.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.12
9-Day RSI 47.12
14-Day RSI 50.22
6-1 Month Momentum % 45.57
12-1 Month Momentum % 43.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.52
Quick Ratio 7.79
Cash Ratio 7.38
Days Inventory 322.26
Days Sales Outstanding 19.18
Days Payable 281.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.5
Shareholder Yield % 0.05

Financials

ASX:IMC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Immuron Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 3.577
EPS (TTM) (A$) -0.017
Beta 0.36
Volatility % 66.19
14-Day RSI 50.22
14-Day ATR (A$) 0.011078
20-Day SMA (A$) 0.10765
12-1 Month Momentum % 43.75
52-Week Range (A$) 0.065 - 0.17
Shares Outstanding (Mil) 227.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immuron Ltd Filings

Filing Date Document Date Form
No Filing Data

Immuron Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Immuron Ltd Frequently Asked Questions

What is Immuron Ltd(ASX:IMC)'s stock price today?
The current price of ASX:IMC is A$0.11. The 52 week high of ASX:IMC is A$0.17 and 52 week low is A$0.07.
When is next earnings date of Immuron Ltd(ASX:IMC)?
The next earnings date of Immuron Ltd(ASX:IMC) is .
Does Immuron Ltd(ASX:IMC) pay dividends? If so, how much?
Immuron Ltd(ASX:IMC) does not pay dividend.

Press Release

Subject Date
No Press Release